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Rhinoviruses and enteroviruses are leading causes of 
respiratory infections. To evaluate genotypic diversity and 
identify forces shaping picornavirus evolution, we screened 
persons with respiratory illnesses by using rhinovirus-spe-
ciﬁ  c or generic real-time PCR assays. We then sequenced 
the 5′ untranslated region, capsid protein VP1, and protease 
precursor 3CD regions of virus-positive samples. Subse-
quent phylogenetic analysis identiﬁ  ed the large genotypic 
diversity of rhinoviruses circulating in humans. We identiﬁ  ed 
and completed the genome sequence of a new enterovirus 
genotype associated with respiratory symptoms and acute 
otitis media, conﬁ  rming the close relationship between rhi-
noviruses and enteroviruses and the need to detect both 
viruses in respiratory specimens. Finally, we identiﬁ  ed re-
combinants among circulating rhinoviruses and mapped 
their recombination sites, thereby demonstrating that rhi-
noviruses can recombine in their natural host. This study 
clariﬁ  es the diversity and explains the reasons for evolution 
of these viruses.
H
uman rhinoviruses (HRVs) and enteroviruses (HEVs) 
are leading causes of infection in humans. These 2 pi-
cornaviruses share an identical genomic organization, have 
similar functional RNA secondary structures, and are classi-
ﬁ  ed within the same genus (www.ictvonline.org/virusTax-
onomy.asp) because of their high sequence homology (1). 
However, despite their common genomic features, these 2 
groups of viruses have different phenotypic characteristics. 
In vivo, rhinoviruses are restricted to the respiratory tract, 
whereas enteroviruses infect primarily the gastrointestinal 
tract and can spread to other sites such as the central ner-
vous system. However, some enteroviruses exhibit speciﬁ  c 
respiratory tropism and thus have properties similar to rhi-
noviruses (2–5). In vitro, most HRVs and HEVs differ by 
their optimal growth temperature, acid tolerance, receptor 
usage, and cell tropism. The genomic basis for these phe-
notypic differences between similar viruses is not yet fully 
understood.
HRVs and HEVs are characterized by ≈100 serotypes. 
Recently, molecular diagnostic tools have shown that this 
diversity expands beyond those predeﬁ  ned serotypes and 
encompasses also previously unrecognized rhinovirus and 
enterovirus genotypes. As an example, a new HRV lineage 
named HRV-C was recently identiﬁ  ed and now comple-
ments the 2 previously known A and B lineages (6–8) (N.J. 
Knowles, pers. comm.). The C lineage has not only a dis-
tinct phylogeny (9–16) but is also characterized by speciﬁ  c 
cis-acting RNA structures (17).
In this study, we screened a large number of persons 
with acute respiratory diseases by using assays designed to 
overcome the diversity of both rhinoviruses and enterovi-
ruses circulating in humans. Whenever possible, we sys-
tematically sequenced 5′ untranslated region (UTR), capsid 
protein VP1, and protease precursor 3CD regions of strains. 
Our goals were 1) to characterize the diversity of circulat-
ing rhinoviruses and, to a lesser extent, enteroviruses, to 
identify putative new picornavirus variants, and 2) to assess 
whether recombination may drive HRV evolution, which 
has not been shown in natural human infections (18).
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Materials and Methods
RNA Extraction, Reverse Transcription-PCR, 
and Real-Time PCR
Reverse transcription–PCR (Superscript II; Invitrogen, 
Carlsbad, CA, USA) was performed on RNA extracted by 
using the HCV Amplicor Specimen Preparation kit (Roche, 
Indianapolis, IN, USA), TRIzol (Invitrogen), or the QIAamp 
Viral RNA Mini kit (QIAGEN, Valencia, CA, USA). 
Real-time PCR speciﬁ  c for HRV-A, HRV-B, and HEV 
(19), and a generic panenterhino real-time PCR (forward 
primer 5′-AGCCTGCGTGGCKGCC-3′, reverse primer 
5′-GAAACACGGACACCCAAAGTAGT-3′, and probe 
5-FAM-CTCCGGCCCCTGAATGYGGCTAA-TAMRA-
3′), were performed in several cohort studies (Table).
Clinical Specimens
Picornavirus-positive samples were detected from 
patients enrolled in cohort studies in different regions of 
Switzerland during 1999–2008. The main characteristics 
of these populations, type of respiratory specimens, and 
screening methods are shown in the Table. The rhinovirus 
serotypes used for 3CD sequencing were obtained from the 
American Type Culture Collection (Manassas, VA, USA).
PCR and Sequencing
Sequencing was performed directly from the clinical 
specimen except for samples selected by routine isolation 
methods on human embryonic (HE) primary ﬁ  broblast cell 
lines (Table) or for HRV reference serotypes. Primers used 
to amplify the 5′-UTR and the VP1 and 3CD regions are 
listed in online Technical Appendix 1 Table 1A (available 
from www.cdc.gov/EID/content/15/5/719-Techapp1.pdf).
Full-length genome sequences of CL-1231094, a re-
lated clinical strain of enterovirus, and partial sequences 
of CL-Fnp5 and CL-QJ274218 were obtained as follows. 
RNA extracted by using the QIAamp Viral RNA Mini kit 
(QIAGEN) plus DNase treatment or with Trizol was re-
verse transcribed with random-tagged primer FR26RV-N 
and ampliﬁ  ed with the SMART RACE cDNA Ampliﬁ  -
cation kit (Clontech, Mountain View, CA, USA) with a 
speciﬁ  c forward primer and FR20RV reverse primer (on-
line Technical Appendix 1 Table 1B) (23). Ampliﬁ  cation 
products were separated by electrophoresis on agarose 
gels and fragments (0.6–2.5 kb) were extracted by us-
ing the QIAquick Gel Extraction kit (QIAGEN). Puriﬁ  ed 
products were cloned by using the TOPO TA cloning kit 
(Invitrogen).
Minipreps were prepared from individual colonies 
and clones with the largest inserts were chosen for se-
quencing. Sequences obtained were used to design a new 
forward primer (online Technical Appendix 1 Table 1) to 
advance toward the 3′ end of the genome. PCR products 
of 3′ genomic ends were obtained by using the BD Smart 
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Table. Characteristics of screened study populations and respiratory samples, Switzerland* 
Type of study (no. 
enrolled)
Age
group Patient characteristics 
Years of 
study 
Type of 
specimens PCR
No. (%) 
positive Reference
Respiratory infection 
in newborns (243) 
<1 y  Nonhospitalized children 
with initial respiratory 
episode with cough 
1999–2005 NPS HRV-A and HRV-B 
specific real time 
for the first 203 and 
panenterhino for 40 
36 (15)  (20)
Lower respiratory 
tract infection in 
hospitalized patients 
(147)
Adults Mainly 
immunocompromised 
patients with lower 
respiratory tract 
complications and 
comorbidities 
2001–2003 BAL, NPS  HRV-A and HRV-B 
specific real time 
16 (11)  (21)
Acute respiratory 
tract infection in 
children (653) 
<17 y  Nonhospitalized children 
with AOM or pneumonia 
2004–2007 NPS Panenterhino 121 (18)  (22) and 
ongoing
study 
Lower respiratory 
tract infection in 
hospitalized patients 
(485)
Adults Mainly 
immunocompromised 
patients with lower 
respiratory tract 
complications and 
concurrent illnesses 
2003–2006 BAL, NPS  Panenterhino 52 (11)  (21) and 
ongoing
study 
Acute respiratory 
tract infection in 
children (64) 
<12 y  Children at an emergency 
department with fever and 
acute respiratory 
symptoms treated with 
antimicrobial drugs 
2006–2007 NPS Panenterhino 23 (36)  NP
Isolation in routine 
procedures (NA) 
Children 
and
adults
Hospitalized patients  1999–2008 BAL, NPS  HE culture isolation  NA NP
*NPS, nasopharyngeal samples; HRV, human rhinovirus; BAL, bronchoalveolar lavage; AOM, acute otitis media; NP, not published; NA, not available; 
HE, human embryonic primary fibroblast cell line.  New Enterovirus and Recombinant Rhinoviruses
Race cDNA ampliﬁ  cation kit (Becton Dickinson, Frank-
lin Lakes, NJ, USA) according to manufacturer’s instruc-
tions. All PCR products were puriﬁ  ed by using microcon 
columns (Millipore, Billerica, MA, USA) and sequenced 
by using the ABI Prism 3130XL DNA Sequencer (Ap-
plied Biosystems, Foster City, CA, USA). Chromato-
grams were imported for proofreading with the vector 
NTI Advance 10 program (Invitrogen). Overlapping frag-
ments were assembled with the contigExpress module of 
the vector NTI Advance 10.
Sequence Analysis, Phylogeny, 
and Bootscanning of Recombinants
Alignments were constructed by using MUSCLE (24) 
with a maximum of 64 iterations. (For detailed analyses, 
see http://cegg.unige.ch/picornavirus.) Multiple FastA was 
converted into PHYLIP format (for tree building) with 
the EMBOSS program Seqret (25). Trees were built with 
PhyML (26) by using the general time reversible model, 
BIONJ for the initial tree, and optimized tree topology and 
branch lengths. Trees with <50 species and larger trees used 
16 and 8 rate categories, respectively. Transition/transver-
sion ratios, proportions of invariant sites, and shape param-
eters of the γ distribution were estimated.
To investigate the hypothesis of recombination 
and map the breakpoints, we adapted the bootscanning 
method (27) as follows. The alignment was sliced into 
windows of constant size and ﬁ  xed overlap and a 100-
replicate maximum-likelihood (using HRV-93 as an out-
group) was computed for each window. From each tree, 
the distance between the candidate recombinant and all 
other sequences was extracted. This extraction yielded a 
matrix of distances for each window and for each align-
ment position. A threshold was deﬁ  ned as the lowest dis-
tance plus a fraction (15%) of the difference between the 
highest and lowest distances. The nearest neighbors of the 
candidate recombinant were deﬁ  ned as sequences at a dis-
tance smaller than this threshold. This distance ensured 
that the nearest neighbor, as well as any close relative, 
was always included. Possible recombination breakpoints 
thus corresponded to changes of nearest neighbors. Sero-
types included in this analysis represented serotypes close 
to CL-013775 and CL-073908 on the basis of 5′-UTR and 
VP1 phlyogenetic trees (online Technical Appendix 2 
Figure 1, panels A, B, available from www.cdc.gov/EID/
content/15/5/719-Techapp2.pdf), as well as serotypes 
close to CL-135587 on the basis of VP1 and 3CD phlyo-
genetic trees (online Technical Appendix 2 Figure 1, pan-
els B, C) and whose full-length sequence was available.
Distance matrices were computed from alignments 
with the distmat program in EMBOSS (http://bioweb2.
pasteur.fr/docs/EMBOSS/embossdata.html) by using the 
Tamura distance correction. This method uses transition 
and transversion rates and takes into account the deviation 
of GC content from the expected value of 50%. Gap and 
ambiguous positions were ignored. Final values were then 
converted to similarity matrices by subtracting each value 
from 100.
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Figure 1. 5′ untranslated region (A), capsid protein VP1 (B), and 
complete genome (C) phylogeny of the virus clades studied. Trees 
were produced by condensing the full phylogeny shown in online 
Technical Appendix 2 Figure 1, panels A, B, and D (available 
from www.cdc.gov/EID/content/15/5/719-Techapp2.pdf). Human 
rhinovirus C′ (HRV-C′) includes the divergent rhinoviruses described 
in 2007 (13) and a related clinical strain (CL-Fnp5). HRV-C includes 
the new clade described since 2006 (9–14,16). Enterovirus 104 
(EV-104) and the related strain CL-1231094 refer to a previously 
unknown enterovirus clade described in this study. In panel C, 
HRV-C′ is shown in brackets to indicate its expected location 
(based on VP1 and 3D sequences). Simian picornavirus 1 (SV2) 
was used as an outgroup. HEV, human enterovirus. Bootstrap 
support values <50 are not shown in the trees. New viruses are 
shown in boldface.RESEARCH
Results
Screening of Persons with Respiratory Tract Infections
Persons enrolled in several cohorts of children and 
adults with respiratory infections (Table) were screened for 
picornavirus by culture isolation on HE cell lines, real-time 
PCR speciﬁ  c for HRV-A and HRV-B (19), or by a panenter-
hino real-time PCR designed to theoretically detect all rhino-
viruses and enteroviruses with publicly available sequences. 
Of 1,592 respiratory samples tested by real-time PCR, 248 
were virus positive (Table). The 5′-UTR sequences were ob-
tained for 77 real-time PCR or culture-positive samples and 
VP1 and 3CD sequences for 48 of these (Table; online Tech-
nical Appendix 1 Table 2). In parallel, the 3CD sequences 
were identiﬁ  ed for all reference serotypes. The results of this 
screening are summarized in online Technical Appendix 1 
Table 2, and all sequences are available from GenBank (ac-
cession nos. EU840726–EU840988).
On the basis of these results, respiratory infections 
caused by HRV-B might be less frequent than those 
caused by HRV-A, and HRV-A infections are distributed 
among the whole library of reference serotypes. A speciﬁ  c 
real-time PCR used to detect enteroviruses in respiratory 
specimens from some of the cohorts studied indicated 
that these viruses are rare in children (2.5% vs. 6.3% for 
HRV) and even rarer or absent in adults (0% vs. 24% for 
HRV) (28).
Phylogeny and Molecular Epidemiology of 5′-UTR
To include all 99 HRV reference strains and new di-
vergent rhinoviruses described recently by Lee et al. (13), 
we reconstructed a phylogenetic tree (online Technical 
Appendix 2 Figure 1, panel A) on the basis of a sequence 
of 280 nt in the 5′-UTR. This sequence provided a correct 
clustering of HRV-A, HRV-B, and HEV strains according 
to the accepted whole-genome phylogeny (online Techni-
cal Appendix 2 Figure 1, panel D) (15) but did not resolve 
appropriately the phylogeny of the 4 HEV species and the 
HRV-A and HRV-C viruses. The condensed tree version 
(Figure 1, panel A) enabled us to identify 2 groups phylo-
genetically distant from all previously known HRVs and 
HEVs. The ﬁ  rst group, referred to as HRV-C′, contained 
some of our clinical samples and rhinoviruses sequenced 
by Lee et al. (13). The second group was a new clade and 
was named EV-104. This clade included 8 clinical sam-
ples collected in different regions of Switzerland without 
direct epidemiologic links (online Technical Appendix 1 
Table 2).
Identiﬁ  cation of HRV-C Viruses by 
Sequencing of HRV Viruses with Divergent 5′-UTRs
Characterization of HRVs newly identiﬁ  ed  during 
2006–2008 showed that they all belong to the same HRV-C 
species (9–16). Recently, Lee et al. (13) identiﬁ  ed another 
cluster of viruses (HRV-C′; Figure 1, panel A) and sug-
gested that this group was phylogenetically distinct from 
all other HRVs on the basis of analysis of their 5′-UTR 
sequences. To deﬁ  ne the phylogeny, we adapted a previ-
ously described method (23) to complete the genome se-
quence directly from our clinical strains (CL-Fnp5 and CL-
QJ274218) that showed a similar divergent 5′-UTR (online 
Technical Appendix 2 Figure 1, panel A). A condensed 
version (Figure 1, panel B) of the phylogenetic tree based 
on VP1 sequences (online Technical Appendix 2 Fig-
ure 1, panel B) indicated that CL-Fnp5 clustered with the 
new HRV-C clade, a ﬁ  nding further conﬁ  rmed by CL-QJ 
274218 partial sequences. This ﬁ  nding supports the view 
that new HRVs variants described since 2006 (9–16) all 
belong to the same lineage.
New Divergent Lineage of HEV Species C
As shown in Figure 1, panel A, the panenterhino real-
time PCR enabled detection of a new HEV strain phyloge-
netically distinct from all previously known HEV species 
and associated with respiratory diseases. Enterovirus-spe-
ciﬁ  c real-time PCRs or reference VP1 primer sets routinely 
used to type enteroviruses (primers 222 and 224 and nested 
primers AN88 and 89) (29,30) did not amplify this new 
genotype. We could not grow this virus on HeLa and HE 
cell lines. Consequently, we applied the method described 
above to complete the genome sequence directly from the 
CL-1231094 (EU840733) clinical specimen. VP1 and full-
length genome sequences showed that, albeit divergent at 
the 5′-UTR level, this new variant belonged to the HEV-C 
species (Figure 1, panels B, C). Full-length genome phy-
logenetic tree (Figure 2) and VP1 protein identity plots 
(online Technical Appendix 2 Figure 2) with all members 
of the HEV-C species indicated that this virus represents 
a new HEV-C genotype that shares 68%, 66%, and 63% 
nucleotide and 77%, 75%, and 68% amino acid sequence 
identity, respectively, with coxsackieviruses A19 (CV-
A19), A22, and A1, the closest serotypes. This new virus 
was named EV-104 (www.picornastudygroup.com/types/
enterovirus_genus.htm).
Speciﬁ   c primers (Ent_P1.29/P2.13 and Ent_P3.30/
P3.32; online Technical Appendix 1 Table 1C) were then 
designed to amplify the VP1 and 3D regions of the 7 other 
samples of this cluster collected from children with acute 
respiratory tract infections and otitis media. VP1 nucleotide 
homology among these strains was 94%–98%, except for 1 
distantly related sample (74%–76%), which may represent 
an additional genotype. Additional sequencing is ongoing 
to verify this assumption.
At the 5′-UTR level, the strain described by Lee et al. 
(13) and EV-104 diverged from other members of HRV-C 
and HEV-C species, respectively. Thus, the 5′-UTR–based 
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phylogeny was inconsistent with that based on VP1 se-
quences and suggested possible recombination events (Fig-
ure 1, panels A, B). Because the 5′-UTR is the target of 
most molecular diagnostic assays, this sequence divergence 
needs to be taken into account in future studies.
Recombination Events between 5′-UTR, 
VP1, and 3CD Genome Regions
Other studies have provided sequences of clinical 
strains, but genetic characterization was often limited to 
1 genomic region. Our goal was to sequence 3 genomic 
regions for each analyzed strain to determine deﬁ  nitively 
whether recombination events could represent a driving 
force for the evolution of rhinoviruses in their natural en-
vironment. Although recombination events have been sug-
gested for reference serotypes, they have never been shown 
for circulating clinical strains (18,31,32). In contrast, re-
combination is well established as a driving force of en-
terovirus evolution. Thus, we completed the 5′-UTR, VP1, 
and 3CD sequences of 43 clinical strains by using a pool 
of adapted and degenerated primers (online Technical Ap-
pendix 1 Table 1A).
Independent phylogenetic trees (online Technical Ap-
pendix 2) and similarity matrices were constructed for the 3 
genomic regions. Since the last common ancestor and as de-
picted on the distance matrices and highlighted by boxplots 
of maximum-likelihood branch length distributions (online 
Technical Appendix 2 Figure 3), there are more mutations 
ﬁ  xed in the VP1 region than in the 3CD region, and more 
in the 3CD region than in 5′-UTR, which is indicative of 
a variable rate of evolution in these regions. Accordingly, 
VP1 sequences enabled genotyping of all but 3 clinical 
strains analyzed (online Technical Appendix 2, Figure 1, 
panel B). These strains may represent rhinovirus genotypes 
only distantly related to predeﬁ  ned reference serotypes. In 
contrast, genotyping based on 3CD and 5′-UTR was less 
accurate, as expected. These results conﬁ  rmed that molecu-
lar typing of rhinoviruses, similarly to other picornaviruses, 
must use capsid sequences.
Phylogeny of the 5′-UTR, VP1, and 3CD of reference 
serotypes showed many incongruities caused by insufﬁ  -
cient tree resolution or recombinant viruses as previously 
proposed (18,31). As an example, 2 VP1 clusters including 
HRV-85/HRV-40 and HRV-18/HRV-50/HRV-34 (online 
Technical Appendix 2 Figure 1, panel B) were reorganized 
as HRV-85/HRV-18/HRV-40 and HRV-50/HRV-34, re-
spectively, on 3CD (online Technical Appendix 2 Figure 
1, panel C). The differential cosegregations between these 
virus strains suggested recombination events. When avail-
able, full-length genome sequence bootscanning applied to 
all serotypes will give an estimate of the number of refer-
ence strains with mosaic genomes.
Similarly, the noncoding region, VP1, and 3CD trees 
showed major phylogenetic incongruities for 3 clinical iso-
lates (online Technical Appendix 2 Figure 1). Two of these 
isolates (CL-013775 and CL-073908) were typed as HRV-
67 on the basis of VP1 sequence and were closest to this 
serotype in 3CD, whereas the 5′-UTR cosegregated with 
HRV-36 (see 5′-UTR recombinant; online Technical Ap-
pendix 2 Figure 1, panels A–C). These viruses were isolated 
by cell culture from 2 epidemiologically linked cases and 
thus represented transmission of the same virus. To conﬁ  rm 
the recombination, we completed the sequencing by obtain-
ing the 5′-UTR, VP4, and VP2 sequences (EU840918 and 
EU840930) and compared them with HRV-36, HRV-67, 
and other closely related serotypes. Bootscanning analysis 
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Figure 2. Full genome phylogenetic tree of enterovirus 104 (EV-
104), representative strain CL-1231094, and members of the 
human enterovirus C (HEV-C) species. Human rhinovirus A (HRV-A) 
(GenBank accession no. DQ473509) was used as outgroup. 
Coxsackievirus A1 (CV-A1) (AF499635), CV-A21 (AF546702), CV-
A20 (AF499642), CV-A17 (AF499639), CV-A13 (AF499637), CV-
A11 (AF499636), CV-A19 (AF499641), CV-A22 (AF499643), CV-
A24 (D90457), poliovirus 1 (PV-1) (V01148), PV-2 (X00595), and 
PV-3 (X00925) sequences were obtained from GenBank. RESEARCH
(Figure 3, panel A) enabled mapping of the recombination 
site within the 5′-UTR, just before the polyprotein start 
codon. Sequence alignment mapped recombination break-
points more precisely between positions 524 and 553 with 
reference to HRV-2 (X02316).
The other incongruent isolate (CL-135587) was typed 
as HRV-76 on the basis of VP1 sequence and was closest 
to this serotype in the 5′-UTR, but 3CD cosegregates with 
HRV-56 (3C recombinant; online Technical Appendix 2 
Figure 1, panels B, C). Similarly, we completed the full-
length sequence of this isolate (EU840726) and HRV-56 
(EU840727). The same approach enabled mapping of the 
recombination site at the N terminus of protein 3C be-
tween positions 1511 and 1523 with reference to HRV-2 
(Figure 3, panel B). These results demonstrate that re-
combination occurs among clinical rhinoviruses. In our 
analysis of 40 rhinovirus-positive samples collected over 
9 years (3 additional samples were duplicates of 2 differ-
ent viruses; online Technical Appendix 1 Table 2) for 3 
genomic regions, 2 of the analyzed viruses appeared to 
be recombinants. The 2 documented recombinations oc-
curred in members of the HRV-A species. The design of 
this study and technical issues (e.g., inability to sequence 
low viral loads) limited the ability to calculate a recombi-
nation rate, particularly for HRV-B and HRV-C.
Discussion
Our genomic analysis of picornaviruses associated 
with upper or lower respiratory diseases in adults and chil-
dren indicates that rhinoviruses circulating in the commu-
nity are widely diverse. The large number of circulating 
genotypes supports the view that rhinoviruses do not circu-
late by waves or outbreaks of a given dominant genotype, 
which might explain the high frequency of reinfection dur-
ing short periods. As expected, the observed variability is 
higher for surface capsid proteins, the targets of most im-
mune pressure, and this region remains the only accurate 
one for genotyping and deﬁ  ning phylogeny. Technical con-
straints such as the limited amount of clinical specimens, 
the use of different screening methods, and the need to 
sequence an unknown target of extreme variability might 
have limited the representativeness of our sequence col-
lection. Therefore, our study should not be considered as 
an exhaustive epidemiologic analysis of rhinoviruses and 
enteroviruses associated with respiratory diseases.
By using a systematic approach, we have identiﬁ  ed a 
new enterovirus genotype (EV-104) that has a divergent 
5′-UTR. Undetectable by conventional methods, EV-104 
could be detected by using a more generic real-time PCR 
assay designed to match all known available rhinovirus and 
enterovirus sequences. Such diagnostic tools have and will 
lead to constant discovery of new picornavirus genotypes 
(9–14,16,33–36). These genotypes may represent viruses, 
in most instances, that have remained undetected because 
of insensitive cell cultures or overly restrictive molecular 
tools. In addition, enterovirus genotypes causing respira-
tory infections, such as EV-68 and CV-A21, might be un-
derrepresented because enteroviruses are usually searched 
for in fecal specimens (37).
EV-104 belongs to the HEV-C species: CV-A19, CV-
A22, and CV-A1 are its closest serotypes. These HEV-C 
subgroup viruses are genetically distinct from all other 
serotypes of the species. These viruses show no evidence 
of recombination with other HEV-C strains and, similar 
to EV-104, do not grow in cell culture (29). On the basis 
of our epidemiologic data, we conclude that EV-104 was 
found in 8 children from different regions of Switzerland 
who had respiratory illnesses such as acute otitis media or 
pneumonia. Future studies using adapted detection tools 
will provide more information on the range of this virus. 
On the basis of its genomic features and similarities with 
coxsackieviruses and poliovirus, EV-104 could theoreti-
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Figure 3. Nearest-neighbor relatedness of rhinovirus CL-013775 
(and CL-073908) along the 5′ untranslated region/VP4/VP2 region 
(A), and nearest-neighbor relatedness of rhinovirus CL-135587 
along the complete genome (B), identiﬁ   ed by bootscanning. At 
each position of a sliding window, the solid circles indicate the 
closest relative within a deﬁ   ned threshold of the phylogenetic 
distance to CL-013775 (A) and CL-135587 (B). Both panels show 
phylogenetic trees of analyzed serotypes over the entire scanned 
region. Human rhinovirus 7 (HRV-7), -9, -10, -11, -24, -32 (accession 
nos. EU096019, AF343584), -36, -39, -44, -56, -58 (EU096045, 
AY040236), -59, -67 (EU096054, AF343603, and DQ473505), -76, 
-88, and -89 sequences were obtained from GenBank (see online 
Technical Appendix 2 Figure 1, available from www.cdc.gov/EID/
content/15/5/719-Techapp2.pdf, for full-length genome accession 
numbers).New Enterovirus and Recombinant Rhinoviruses
cally infect the central nervous system (2,38). Detection of 
new subtypes of picornaviruses indicates that viruses with 
new phenotypic traits could emerge, and conclusions on 
tropism of new strains should be substantiated by extensive 
experimental or clinical investigations (39).
By completing the sequence of a seemingly divergent 
rhinovirus (13), we assigned this virus to the new HRV-C 
species, thus limiting currently to 3 the number of HRV 
species. For the sake of simplicity, we propose to consider 
this virus as a member of the HRV-C clade.
Finally, we demonstrated that rhinovirus evolves by 
recombination in its natural host. Known to be a driving 
force of enterovirus evolution, rhinovirus recombination 
among clinical strains has never been observed. Two clini-
cal isolates of 40 viruses analyzed resulted from recombi-
nation events and their breakpoints were identiﬁ  ed within 
the 5′-UTR sequence and the N terminus of protein 3C, re-
spectively. These ﬁ  ndings are consistent with the fact that 
recombination breakpoints in picornaviruses are restricted 
to nonstructural regions of the genome or between the 5′-
UTR and the capsid-encoding region (40). Our observa-
tions provide new insight on the diversity and ability of 
rhinovirus to evolve in its natural host. The fact that only 
2 of 40 analyzed viruses over a 9-year period were recom-
binants is suggestive of a lower recombination frequency 
in rhinoviruses than in other picornaviruses (32,40) and 
might be related, but not exclusively, to the short duration 
of rhinovirus infection (18,31,32). Recombination events 
occurred between HRV-A genotypes, but whether they can 
occur in species B and C remains unknown. Interspecies 
recombination is rare in picornaviruses and is mainly the 
result of in vitro experiments. For rhinoviruses, the differ-
ent location of cre elements in each species might be an 
additional limiting constraint (17).
In summary, we have highlighted the large genomic di-
versity of the most frequent human respiratory viral infec-
tion. Our phylogenetic analysis has characterized circulat-
ing strains relative to reference strains and has identiﬁ  ed a 
previously unknown enterovirus genotype. We have shown 
that recombination also contributes to rhinovirus evolution 
in its natural environment.
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